D Srinivasa Reddy takes over as Director CSIR-IICT
Reddy will also hold the additional charge of the post of director of CSIR-IIIM, Jammu and director, CSIR-CDRI, Lucknow
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
AI for drug development: How trustworthy is the tech?
Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
There's an unhealthy alliance between doctors and pharma firms
The government has shown little interest to penalise pharma companies that offer sops to doctors to push their drugs
COVID-19 vaccines for all: Will Sputnik V speed up vaccination in India
Sputnik V’s entry may not dent the ongoing vaccine shortage in India, but its domestic production could change things by year-end
'India’s drug dependence on China not good for its health sector'
Setting up of large-scale pharma and chemical clusters in proximity to each other can help sector perform better, says industry body ASSOCHAM
It is critical to view antimicrobial resistance through a multi-dimensional lens
Reducing pollution from the pharmaceutical, agricultural and healthcare sectors is needed to reduce the emergence, transmission and spread of …
India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated
Of 175 drug combinations used to treat pain-relief, diabetes, anxiety/depression, and psychosis, a study found that 115 combinations had no …
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
After cough-syrup, now eye drops: India-made solution causes 1 death, several infections in US
This could be particularly damning for India’s drug regulatory system since it is coming on the heels of cough-syrup-associated deaths in …
New hepatitis drug to cost more in middle income nations; activists cry foul
Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …
How dosage of fever drugs has again highlighted nexus of pharma firms, doctors
No regulation on marketing strategies by drug companies has created a medical autocracy, the Dolo-650 controversy shows
Modi Cabinet approves 100% FDI in medical devices sector via automatic route
Existing conditions and prior approval required in case of merger and acquisition done away with
Sun-Ranbaxy merger: CCI says deal may hurt competition, seeks public opinion
The merger would lead to creation of the world's fifth-largest maker of generic drugs
2022 Chemistry Nobel awarded for ‘click chemistry’, which has possible applications in healthcare
Carolyn Bertozzi, Morten Meldal and Barry Sharpless worked on click chemistry, or linking chemicals together, and biorthogonal reactions, …
Sun Pharma, Novartis settle lawsuit over Glivec
Sun Pharma allowed to launch generic version of anti-leukamia drug next year
That which is injurious to health
Book>> Bad Pharma • by Ben Goldacre • Fourth Estate • £13
No veterinary drug given to Jodhpur hospital; just a case of wrong labelling, says company
Rajasthan government sets up committee to probe administration of injections from vials labelled 'for animal treatment'
Industries can harm health in many ways: Here are 3 that aren’t so obvious
Some products and practices are directly linked to avoidable ill health, planetary damage and social and health inequity, especially by …
Ban FDI in brownfield pharma, says Parliament standing committee
Panel raises alarm over continuing takeover of Indian generic drug firms by multinational companies
The NATCO CL fallout
The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market
Maharashtra bans anti-tick medication temporarily
26 heads of cattle killed after being administered injection in Parbhani district
Pharma lobby obtains stay on Centre’s drug price control order
Drug manufacturers also trying to scuttle government’s drug pricing policy
A patent triumph of public interest
New flexibilities make public interest safeguards integral to drug patent rights